Abstract:
The screening data on the antitumor activity of 207 compds, were reported. Most of the effective compds, were nitrogen mustard derivatives, among which M
2 (N-formylsarcolysine), M
3 (N-acetylsarcolysine), M
4 (N-formylsarcolysine phenylalanine), M
5 (Glutamylsarcolysine), M
9 (Ethyl-
α-nitro-
β-di-(2-chloroethyl) amino caproate), M
10 (Ethyl-
α-nitro-
β-di-(2-chloroethyl)amino-
β-(
p-dimethylaminophenyl)-propionate) were most potent. Among these, M
2 (N-formylsarcolysine) and M
1 (N-formylsarcolysine phenylalanine)have been recommended for clinical trials.